Overview

The France Foundation is accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME) as a provider of education for physicians.

The France Foundation is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing education for pharmacists.


2019 Fall Conference Coverage: Live from New Orleans!

Independent Conference Coverage from the CHEST 2019 Annual Meeting
The France Foundation

2019 Winter Conference Coverage

All eyes are on this season’s new developments in ILD management and diagnosis.
The France Foundation

Advances in Multiple Sclerosis (AIMS) Primer: Third Edition

The third edition of the Advances in Multiple Sclerosis Primer provides an educational experience featuring interactive cases and expert faculty commentary on a variety of MS topics. The content contains many recent updates to the second edition, as well as new sections including diagnosis and continuity of care.
The France Foundation

Clearing the Air on Chuck’s Asthma

LEARNING OBJECTIVES Upon completion of the activity, participants should be able to: Perform a thorough assessment of asthma severity and control in day-to-day practice Explain how mechanisms of action of new/emerging type 2 inflammation-directed treatments address the underlying immunology of asthma Select appropriate type 2 inflammation-targeted therapies on the basis of safety and effic...
The France Foundation

Eugene’s U(I)P-Hill Battle

Upon completion of the activity, participants should be able to: Use a multidisciplinary approach based on ATS/ERS guidelines for diagnosing IPF Incorporate new findings/recommendations into the diagnostic process for IPF Recognize signs and symptoms that may indicate IPF Provide rationales for starting treatment Use strategies for mitigating IPF treatment side effects and increasing adhe...
The France Foundation

Evaluation and Diagnosis of IPF

Marilyn K. Glassberg, MD discusses IPF comorbidities, diagnosis of IPF, and the importance of patient education. Included in this webinar are panel interviews with IPF experts and a patient with IPF!
The France Foundation

Experts Report the Latest Updates in Pulmonary Disease

Upon completion of the activity, participants should be able to: Review new information on the management of patients with IPF Discuss the implication of this new information on current clinical practices for pulmonology clinicians
The France Foundation

How would you Manage President Teddy Roosevelt’s Asthma Today?

LEARNING OBJECTIVES Upon completion of the activity, participants should be able to: Explain how phenotypes and endotypes can help guide a precision medicine approach to severe asthma Summarize mechanisms of action and key efficacy and safety data pertaining to biologics used in severe asthma Apply information on phenotypes and endotypes and biologics to precision therapy, as part of a...
The France Foundation

Initial Treatment Decisions

Marilyn K. Glassberg, MD provides examples of shared decision-making with a patient, ongoing clinical trials, and treatment progression. Included in this webinar are panel interviews with IPF experts and a patient with IPF!
The France Foundation

Is Mary’s PAH Making You Dizzy?

Upon completion of the activity, participants should be able to: Choose optimal, recommended testing that can help confirm PAH diagnosis Summarize available and emerging treatment options for PAH, including combination approaches
The France Foundation

New Paradigms in the Management of Locally Advanced or Metastatic CSCC

In this activity, Dr. Michael Wong explains how to apply evidence and evidence-based recommendations to the selection of radiation, surgery, and/or systemic pharmacologic therapy. Later, he is joined by Dr. Chrysalyne Schmults to discuss a unique patient case.
The France Foundation

Optimizing Management of IPF

Lisa H. Lancaster, MD reviews management strategies for medication side effects, pulmonary rehabilitation and patient education. Included in this webinar are panel interviews with IPF experts and a patient with IPF!
The France Foundation

Personalized Medicine for Improving Asthma Care: An Animated Video Series

In this series of fast-paced animated videos, Dr. Tara Carr discusses the treatment of severe asthma, including how to choose targeted therapy based on patient endotypes and phenotypes.
The France Foundation

PILOTforPulmonary 2019: Data, Insights & Practice

This education provides the opportunity to learn the latest in the management of patients with IPF/ILD. Summaries or abstracts from recent pulmonary meetings will be presented followed by video discussions by expert faculty regarding the implications on the management of patients with IPF/ILD. Skills can then be applied in an interactive case where the learner is challenged to make decisions for...
The France Foundation

Shedding Light on Jane’s ILD Diagnosis

Upon completion of the activity, participants should be able to: Use a multidisciplinary approach based on ATS/ERS guidelines for diagnosing IPF Incorporate new findings/recommendations into the diagnostic process for IPF Recognize signs and symptoms that may indicate IPF Provide rationales for starting treatment Use strategies for mitigating IPF treatment side effects and increasing adhe...
The France Foundation

The Evidence So Far: Risk, Referral, and What's New in Advanced CSCC Care

In this activity, listen to CSCC expert Dr. Michael Wong discuss how to recognize risk for CSCC in your patients, as well as the emerging treatment options that are changing the way patients with CSCC are treated. Later, he is joined by Dr. Chrysalyne Schmults to review a patient case and discuss the optimal approach to multidisciplinary care for the patient.
The France Foundation

The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring

Rheumatologists who manage patients with SLE are faced with a myriad of challenges. Objective tests and tools that can help to fully assess symptoms, flare, treatment response, and damage accrual must be better understood and employed. Established and emerging therapies (including combinations) must be considered and used prudently, with an eye toward establishing treatment priorities and balanc...
The France Foundation

The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence

Rheumatologists who manage patients with SLE are faced with a myriad of challenges. Objective tests and tools that can help to fully assess symptoms, flare, treatment response, and damage accrual must be better understood and employed. Established and emerging therapies (including combinations) must be considered and used prudently, with an eye toward establishing treatment priorities and balanc...
The France Foundation

Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?

Upon completion of the activity, participants should be able to: Choose diagnostic interventions (including consultations with other specialties) that can help confirm the necessary diagnosis of exclusion for sarcoidosis
The France Foundation

Updates in Atopic Dermatitis: Diagnosis and Management in Adults

The prevalence of atopic dermatitis (AD) in industrialized nations is estimated at up to 30% for children and up to 10% for adults. The vast majority (85%) of affected patients develop symptoms before reaching their 5th birthday. For children, severity can increase with age although in 70% of childhood cases AD remits by adolescence. Allergist/immunologists often receive referrals of these chall...
The France Foundation

Updates in Atopic Dermatitis: Diagnosis and Management in Infants and Children

The prevalence of atopic dermatitis (AD) in industrialized nations is estimated at up to 30% for children and up to 10% for adults. The vast majority (85%) of affected patients develop symptoms before reaching their 5th birthday. For children, severity can increase with age although in 70% of childhood cases AD remits by adolescence. Allergist/immunologists often receive referrals of these chall...
The France Foundation

What if President Calvin Coolidge Was Your Asthma Patient?

Explain how phenotypes and endotypes can help guide a precision medicine approach to severe asthma Summarize mechanisms of action and key efficacy and safety data pertaining to biologics used in severe asthma Apply information on phenotypes and endotypes and biologics to precision therapy, as part of a personalized treatment selection process
The France Foundation

What is Your Treatment Recommendation for Sandra’s CTEPH?

LEARNING OBJECTIVES Upon completion of the activity, participants should be able to: Select optimal, recommended testing to confirm CTEPH diagnosis Summarize available and emerging treatment options for inoperable CTEPH Discuss radiological tests and features that can help differentiate CTEPH from other pulmonary diseases
The France Foundation

When Should You Consider Palliative Care in the Patient Journey?

Upon completion of the activity, participants should be able to: Formulate a management plan that optimizes collaboration with other care providers
The France Foundation

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.